Sponsored Projects Administration

Expedited drug approvals raise questions

Published November 12, 2013 by OSP


Over the past few years, the FDA has been hurtling toward increasingly speedier approvals for certain drugs as a growing cadre of patients, investors and politicians demand the agency move faster to satisfy unmet medical needs. As a result, the approach taken for approving drugs for AIDS, cancer, and other life-threatening conditions is gradually being applied to treatments for a wider variety of illnesses.

Read More>